Condition
Breast Cancer Subjects
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Leuprorelin Acetate Microspheres For Injection
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Leuprorelin Acetate Microspheres For Injection1
- T Leuprolide Injectable Emulsion1
Active Sponsors
- Changchun GeneScience Pharmaceutical Co., Ltd.1
Top Investigators
Fudan University
Fudan University